Opus Genetics Inc (IRD) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Opus Genetics Inc   (NASDAQ: IRD)

Select the Financial Report: Select the Period:


Description of Opus Genetics Inc's Business Segments
The Company operates in a single reportable segment focused on the development of products related to vision performance and health. The Chief Executive Officer, serving as the chief operating decision maker, regularly reviews the financial information of this segment to allocate resources and evaluate performance. The consolidated financial statements present profit or loss measures, expense categories, and other financial data pertinent to this segment.

Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Composition of Opus Genetics Inc Revenues by Segments
 
Viatris License Agreement    101.99 % of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)		 %
(of total Revenues)
Viatris License Agreement 2.20 101.99 %
Total 2.16 100 %




Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%		 Q/Q Revenue
%
Viatris License Agreement -50 % -
Total -50.64 % -84.81 %




Q1 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)		 %
(Profit Margin)
Total -65.54 -




Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%		 Q/Q Income
%
Total - -




Annual Report on Opus Genetics Inc Divisions, Sales by Country

 


Twelve months ended 2025
IRD s Annual Revenue by Geography and Business Segments Sales
(in millions $)		 %
(of total Sales)
Total 14.20 100 %


Twelve months ended 2025
IRD s Annual Income by Country and Business Segments Income
(in millions $)		 %
(Profit Margin)
Total -49.59 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Total 29.15 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.